ArticleHuman genomics2026
Mutational spectrum of SLC26A4 and SLC26A5 associated with hereditary hearing loss in Moroccan families.
Article in Human genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe solute carrier family 26 (SLC26) encodes multifunctional anion transporters that mediate the transmembrane exchange of monovalent and divalent anions. While pathogenic variants in several SLC26 genes cause inherited disorders, only SLC26A4 and SLC26A5 have been linked to hereditary hearing loss (HHL).
resultsExome sequencing performed in probands from nine unrelated Moroccan families with sensorineural hearing loss identified eight SLC26A4 variants, including previously reported and novel variants, as well as a homozygous canonical splice-site variant in SLC26A5 (c.1311 + 1G > T). Sanger sequencing confirmed co-segregation of all identified variants, and in silico prediction tools consistently supported their pathogenicity. Molecular dynamics simulations performed on three SLC26A4 missense variants (p. Ser353Ala, p. Phe555Cys, and p. Leu582Pro) indicated significant, state-dependent alteration in pendrin's structural stability, suggesting impaired conformational transitions required for efficient Cl⁻/HCO₃⁻ exchange.
conclusionThis study provides a comprehensive molecular characterization of SLC26A4- and SLC26A5-related hearing loss in Moroccan families and significantly expands the mutational landscape of hereditary hearing loss in North Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.